|0.98||-0.0199 / -1.99%|
Data as of 3:59pm ET
|0.95||-0.03 / -3.06%|
The 2 analysts offering 12-month price forecasts for ImmunoCellular Therapeutics Ltd have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +257.14% increase from the last price of 0.98.
The current consensus among 2 polled investment analysts is to Buy stock in ImmunoCellular Therapeutics Ltd. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.